Compugen Ltd

-0.02 (-1.47%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)88.77M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$3.75 Million
Adjusted EPS-$0.09
See more estimates
10-Day MA$1.04
50-Day MA$1.11
200-Day MA$0.93
See more pivots

Compugen Ltd Stock, NASDAQ:CGEN

Azrieli Center, 26 Harokmim Street, Holon, Tel Aviv 58858
Phone: +972.3.765.8585
Number of Employees: 69


Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses on research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel.